Search Results - paul+zarek

1 Results Sort By:
Inducing and Inhibiting T Cell Tolerance with A2a Receptor Agonists and Antagonists
C04897: Inducing and Inhibiting T Cell Tolerance with A2a Receptor Agonists and AntagonistsValue Proposition: • Therapeutic target for developing tolerance-inducing agents and tolerance-inhibiting agents for the treatment of autoimmune disease and cancer • Methods of treating an infection by enhancing the generation of antigen-specific...
Published: 9/26/2024   |   Inventor(s): Paul Zarek, Charles Drake, Jonathan Powell
Keywords(s): Agonists/Promoters, Antagonists/Inhibitors, Autoimmune Diseases, Cancers, Disease Indication, Immunotherapy, Infectious Diseases, Inflammatory Disorders, Non-novel, Predicted Novelty, Repurposed, Single, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Autoimmunity, Clinical and Disease Specializations > Immunology, Clinical and Disease Specializations > Infectious Diseases, Clinical and Disease Specializations > Inflammation, Clinical and Disease Specializations > Oncology, Clinical and Disease Specializations > Rare Diseases, Technology Classifications > Therapeutic Modalities > Immunotherapies, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum